Cite

HARVARD Citation

    Fujii, T. et al. (2021). A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease. Journal of neurochemistry. 159 (3), pp. 543-553. [Online]. 
  
Back to record